CSL Ltd. (CSLLY)
CSL Market Cap: 56.72B for Dec. 19, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Alterity Therapeutics Ltd. | 56.01M |
| Kazia Therapeutics Ltd. | 18.16M |
| Immutep Ltd. | 382.82M |
| Propanc Biopharma, Inc. | 9.502M |
| Mesoblast Ltd. | 2.492B |
Market Cap Related Metrics
| PE Ratio | 18.97 |
| PS Ratio | 3.691 |
| PEG Ratio | 0.5696 |
| Price to Free Cash Flow | 22.22 |
| Price | 58.57 |
| Earnings Yield | 5.27% |
| PEGY Ratio | 0.5299 |
| Operating PE Ratio | 14.13 |
| Normalized PE Ratio | 18.95 |